On March 23, 2026, Onconetix, Inc. announced a reverse stock split of its common stock at a ratio of 1-for-5, effective March 25, 2026, reducing outstanding shares from 3,464,686 to 692,927 shares. The amendment was approved by stockholders on February 3, 2026, and will not change ownership percentages for stockholders, except for fractional shares.